Stray Dog
EN中文

Prices are Hyperliquid perpetual futures: contracts that track each stock and trade 24/7. They are not exchange prices and can differ from them, most of all while US markets are closed. Change is over 24 hours. For information only.

  • TSLA—
  • PLTR—
  • HIMS—
  • SPCX—
  • SOFI—
  • BTC—
…Loading prices
HIMS

Expands its subscription ecosystem with eight new health partners

In an official announcement on 28 May, HIMS said its subscriber benefits programme (Hims & Hers Benefits) has added eight partners. Together with the existing Prenuvo (full-body MRI) and Eight Sleep (smart mattress), there are now 10 brands covering five areas.

CPO quote

Dheerja Kaur: 'Healthcare is at its most powerful when treatment, data, nutrition and fitness work together towards the same goal.'

Existing partners

  • Prenuvo (full-body MRI)
  • Eight Sleep (smart mattress)

Investment significance

  • Stickier subscriptions: members get discounts or free periods across several brands, so switching costs rise significantly
  • Upgraded data loop: Dexcom glucose data, Labs biomarkers and MyFitnessPal diet data combine into a multi-dimensional health data network
  • The platform story becomes concrete: from a telehealth business selling drugs to a health and lifestyle subscription platform
  • iFIT designs AI training plans specifically for GLP-1 users, so the weight-loss business is starting to build a supporting ecosystem and is not just selling drugs

Partners

Fitness
  • iFIT (AI coach, with training tuned specifically for GLP-1 users)
  • Ladder (strength training)
  • PVOLVE Studios (longevity training method)
Metabolic monitoring
  • Dexcom Stelo: FDA-cleared continuous glucose monitor
Nutrition
  • HelloFresh (meal-kit delivery)
  • Factor (ready-to-eat healthy meals)
  • MyFitnessPal (diet tracking)
Women's health
  • Natural Cycles (FDA-cleared contraceptive app)
  • Flo Health (the world's number one period-tracking app)

Price

$25.37 (+7%, extending the rebound that followed Wells's insider purchase)

A brief is a lead for our research, not a verified conclusion or advice.